Action of locally administered NMDA and AMPA/kainate receptor antagonists in spinal cord injury

Neurological Research

Volumn 22, Issue 2, 2000, Pages 171-180

  Shuxin, Li ^a   Tator, Charles H ^a  

^a TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

AMPA kainate receptor; Evoked potentials; Neurotoxicity; NMDA receptor; Spinal cord blood flow; Spinal cord injury

Indexed keywords

6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; AMPA RECEPTOR ANTAGONIST; DIZOCILPINE; KAINIC ACID RECEPTOR ANTAGONIST; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EVOKED BRAIN STEM AUDITORY RESPONSE; EVOKED SOMATOSENSORY RESPONSE; MALE; NERVE FUNCTION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; RAT; SPINAL CORD BLOOD FLOW; SPINAL CORD INJURY;

EID: 0342803565     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1080/01616412.2000.11758605     Document Type: Article

References (71)

1. Regan RF, Choi DW. Glutamate neurotoxicity in spinal cord cell culture. Neuroscience 1991; 43: 585-591
2. Stewart GR, Olney JW, Pathikonda M, Snider WD. Excitotoxicity in the embryonic chick spinal cord. Ann Neurol 1991; 30: 758-766
3. Tymianski M, Charlton MP, Carlen PL, Tator CH. Source specificity of early calcium neurotoxicity in cultured embryonic spinal neurons. J Neurosci 1993; 13: 2085-2104
4. Wells K, Anderson DK, Farooqui AA, Horrocks LA. Excitotoxicity of glutamate and four analogs in primary spinal cord cell cultures. Neurochem lnt 1994; 25: 377-384
5. Faden Al, Ellison JA, Noble LJ. Effects of competitive and noncompetitive NMDA receptor antagonists in spinal cord injury. Eur J Pharmacol 1990; 175: 165-174
6. Ganong AH, Lanthorn TH, Cotman CW. Kynurenic acid inhibits synaptic and acidic amino acid-induced responses in the rat hippocampus and spinal cord. Brain Res 1983; 273: 170-174
7. Kwak S, Nakamura R. Acute and late nebrotoxicity in the rat spinal cord in vivo induced by glutamate receptor agonists. J Neurol Sci 1995; 129 (Suppl): 99-103
8. Demediuk P, Daly MP, Faden Al. Effect of impact trauma on neurotransmitter and nonneurotransmitter amino acids in rat spinal cord. J Neurochem 1989; 52: 1529-1536
9. Farooque M, Hillered L, Holtz A, Olsson Y. Effects of moderate hypothermia on extracellular lactic acid and amino acids after severe compression injury of rat spinal cord. J Neurotrauma 1997; 14: 63-69
10. Farooque M, Hillered L, Holtz A, Olsson Y. Changes of extracellular levels of amino acids after graded compression trauma to the spinal cord: An experimental study in the rat using microdialysis. J Neurotrauma 1996; 13: 537-548
11. Liu D, Tahangnipon W, McAdoo DJ. Excitatory amino acids rise to toxic levels upon impact injury to the rat spinal cord. Brain Res 1991; 547: 344-348
12. Panter SS, Yum SW, Faden Al. Alteration in extracellular amino acids after traumatic spinal cord injury [see comments]. Ann Neurol 1990; 27: 96-99
13. Faden Al, Lemke M, Simon RP, Noble LJ. N-methyl-D-aspartate antagonist MK801 improves outcome following traumatic spinal cord injury in rats: Behavioral, anatomic, and neurochemical studies. J Neurotrauma 1988; 5: 33-45
14. Gomez-Pinilla F, Tram H, Cotman CW, Nieto-Sampedro M. Neuroprotective effect of MK-801 and U-50488H after contusive spinal cord injury. Exp Neurol 1989; 104: 118-124
15. Yanase M, Sakou T, Fukuda T. Role of N-methyl-D-aspartate receptor in acute spinal cord injury. J Neurosurg 1995; 83: 884-888
16. Agrawal SK, Fehlings MG. Role of NMDA and non-NMDA ionotropic glutamate receptors in traumatic spinal cord axonal injury. J Neurosci 1997; 17: 1055-1063
17. Chizh BA, Cumberbatch MJ, Headley PMN. A comparison of intravenous NBQX and GYKI 53655 as AMPA antagonists in the rat spinal cord. Br J Pharmacol 1994; 112: 843-846
18. Lodge D, Jones MG, Palmer AJ. Excitatory amino acids: New tools for old stories or pharmacological subtypes of glutamate receptors: Electrophysiological studies. Can J Physiol Pharmacol 1991; 69: 1123-1128
19. Zeman S, Lodge D. Pharmacological characterization of non-NMDA subtypes of glutamate receptor in the neonatal rat hemisected spinal cord in vitro. Br J Pharmacol 1992; 106: 367-372
20. Rosenberg LJ, Teng YD, Wrathall JR. 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(r)quinoxaline reduces glial loss and acute white matter pathology after experimental spinal cord contusion. J Neurosci 1999; 19: 464-475
21. von Euler M, Seiger A, Holmberg L, Sundstrom E. NBQX, a competitive non-NMDA receptor antagonist, reduces degeneration due to focal spinal cord ischemia. Exp Neurol 1994; 129: 163-168
22. Wrathall JR, Choiniere D, Teng YD. Dose-dependent reduction of tissue loss and functional impairment after spinal cord trauma with the AMPA/kainate antagonists NBQX. J Neurosci 1994; 14: 6598-6607
23. Wrathall JR, Teng YD, Choiniere D. Amelioration of functional deficits from spinal cord trauma with systemically administered NBQX, an antagonist of non-N-methyl-D-aspartate receptors. Exp Neurol 1996; 137: 119-126
24. Garcia-Barcina JM, Matute C. Expression of kainate-selective glutamate receptor subunits in glial cells of the adult bovine white matter. Eur J Neurosci 1996; 8: 2379-2387
25. Matute C, Sanchez-Gomez MV, Martinez-Millan L, Miledi R. Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes. Proc Natl Acad Sci USA 1971; 94: 8830-8835
26. Martin DL. Synthesis and release of neuroactive substances by glial cells. Glia 1992; 5: 81-94
27. Tator CH. Review of experimental spinal cord injury with emphasis on the local and systemic circulatory effects. Neurochirurgie 1991; 37: 291-302
28. Fehlings MG, Tator CH, Linden RD. The relationships among the severity of spinal cord injury, motor and somatosensory evoked potentials and spinal cord blood flow. Electroenceph Clin Neurophysiol 1989; 74: 241-259
29. Li S, Tator CH. AMPA/kainate receptor antagonist NBQX blocks local glutamate excitatory transmission and do not relieve traumatic ischemia following spinal cord injury in rats. Can J Neurol Sci 1997; 24 (Suppl. 1): S29
30. Li S, Tator CH. NMDA and non-NMDA receptor antagonists block local glutamate excitatory transmission and do not relieve traumatic ischemia following experimental spinal cord injury. J Neurotrauma 1998; 15: 27
31. Rivlin AS, Tator CH. Effect of duration of acute spinal cord compression in a new acute cord injury model in the rat. Surg Neurol 1978; 10: 38-43
32. Hurlbert RJ, Koyanagi I, Tator CH. Sensory evoked potentials for selective monitoring of the rat spinal cord: A cerebellar evoked potential to assess ventral cord integrity. J Neurotrauma 1993; 10: 181-200
33. Wrathall JR, Bouzoukis J, Choiniere D. Effect of kynurenate on functional deficits resulting from traumatic spinal cord injury, Eur J Pharmacol 1992; 218: 273-281
34. Benvenga MJ, Spaulding TC. Amnesic effect of the novel anticonvulsant MK-801. Pharmacol Biochem Behav 1988; 30: 205-207
35. Bullock R, Graham DI, Swanson S, McCulloch J. Neuroprotective effect of the AMPA receptor antagonist LY-293558 in focal cerebral ischemia in the cat. J Cereb Blood Flow Metab 1994; 14: 466-471
36. Muir KW, Lees KR. Clinical experience with excitatory amino acid antagonist drugs. Stroke 1995; 26: 503-513
37. Olney JW. Neurotoxicity of NMDA receptor antagonists: An overview. Psychopharmacol Bull 1994; 30: 533-540
38. Fehlings MG, Tator CH, Linden RD, Piper IR. Motor and somatosensory evoked potentials recorded from the rat. Electroenceph Clin Neurophysiol 1988; 69: 65-78
39. Honmou O, Young W. Traumatic injury of spinal axons. In: Waxman SG, Kocsis JD, Stys PK, eds. The Axon: Structure, Function and Pathophysiology, New York: Oxford, 1995: pp. 480-503
40. 2+ exchanger. J Neurosci 1996; 16: 545-552
41. 2+ exchanger. J Neurosci 1992; 12: 430-439
42. Teng YD, Wrathall JR. Local blockade of sodium channels by tetrodotoxin ameliorates tissue loss and long-term functional deficits resulting from experimental spinal cord injury. J Neurosci 1997; 17: 4359-4366
43. Headley PM, Grillner S. Excitatory amino acids and synaptic transmission: The evidence for a physiological function. Trends Pharmacol Sci 1990; 11: 205-211
44. Mayer ML, Westbrook GL. The physiology of excitatory amino acids in the vertebrate central nervous system. Prog Neurobiol 1987; 28: 197-276
45. Watkins JC, Evans RH. Excitatory amino acid transmitters. Annu Rev Pharmacol Toxicol 1981; 21: 165-204
46. Salt TE, Hill RG. Neurotransmitter candidates of somatosensory primary afferent fibres. Neuroscience 1983; 10: 1083-1103
47. Schneider SP, Perl ER. Selective excitation of neurons in the mammalian spinal dorsal horn by aspartate and glutamate in vitro: Correlation with location and excitatory input. Brain Res 1985; 360: 339-343
48. Wilcox GL. Excitatory neurotransmitters and pain. In: Bond MR, Charlton JE, Woolf CJ, eds. Proceedings of the World Congress on Pain: Pain Research and Clinical Management, Amsterdam: Elsevier, 1991: pp. 97-117
49. Yoshimura M, Jessell T. Amino acid-mediates EPSPs at primary afferent synapses with substantia gelatinosa neurones in the rat spinal cord. J Physiol (Lond) 1990; 430: 315-335
50. Matute C. Characteristics of acute and chronic kainate excitotoxic damage to the optic nerve. Proc Natl Acad Sci USA 1998; 95: 10229-10234
51. McDonald JW, Althomsons SP, Hyrc KL, Choi DW, Goldberg MP. Oligodendrocytes from forebrain are highly vulnerable to AMPA/ kainate receptor-mediated excitotoxicity. Nat Med 1998; 4: 291-297
52. Kriegler S, Chiu SY. Calcium signaling of glial cells along mammalian axons. J Neurosci 1993; 13: 4229-4245
53. Li S, Mealing GA, Morley P, Stys PK. Novel injury mechanism in anoxia and trauma of spinal cord white matter: Glutamate release via reverse Na(+)-dependent glutamate transport. J Neurosci 1999; 19: RC16 (1-9)
54. Oka A, Belliveau MJ, Rosenberg PA, Volpe JJ. Vulnerability of oligodendroglia to glutamate: Pharmacology, mechanisms, and prevention. J Neurosci 1993; 13: 1441-1453
55. Turski L, Huth A. Sheardown M, McDonald F, Neuhaus R, Schneider HH, Dirnagl U, Wiegand F, Jacobsen P, Ottow E. ZK200775: A phosphonate quinoxalinedione AMPA antagonist for neuroprotection in stroke and trauma. Proc Natl Acad Sci USA 1998; 95: 10960-10965
56. Honmou O, Sakatani K, Young W. GABA and potassium effects on corticospinal and primary afferent tracts of neonatal rat spinal dorsal columns. Neuroscience 1993; 54: 93-104
57. Sakatani K, Hassan AZ, Chesler M. GABA-sensitivity of dorsal column axons: An in vitro comparison between adult and neonatal rat spinal cords. Brain Res Dev Brain Res 1991; 61: 139-142
58. Sakatani K, Hassan AZ, Ching W. Age-dependent extrasynaptic modulation of axonal conduction by exogenous and endogenous GABA in the rat optic nerve. Exp Neurol 1991; 114: 307-314
59. Lieberman EM, Abbott NJ, Hassan S. Evidence that glutamate mediates axon-to-Schwann cell signaling in the squid. Glia 1989; 2: 94-102
60. Agrawal SG, Evans RH. The primary afferent depolarizing action of kainate in the rat. Br J Pharmacol 1986; 87: 345-355
61. Evans RH, Evans SJ, Pook PC, Sunter DC. A comparison of excitatory amino acid antagonists acting at primary afferent C fibres and motoneurones of the isolated spinal cord of the rat. Br J Pharmacol 1987; 91: 531-537
62. Hawkins NS, Hearn J, Evans RH. Comparison of the capsaicin-and amino acid-sensitivity of dorsal root C fibres in the rat and the toad. Comp Biochem Physiol C 1991; 99: 513-516
63. Ransom BR, Waxman SC, Davis PK. Anoxic injury of CNS white matter: Protective effect of ketamine. Neurology 1990; 40: 1399-1403
64. Ikonomidou C, Qin Qin Y, Labruyere J, Olney JW. Motor neuron degeneration induced by excitotoxin agonists has features in common with those seen in the SOD-1 transgenic mouse model of amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 1996; 55: 211-224
65. 2+-dependent injury of the dorsal columns. J Neurotrauma 1997; 14: 299-311
66. Stys PK, Random BR, Waxman SG, Davis PK. Role of extracellular calcium in anoxic injury of mammalian central white matter. Proc Natl Acad Sci USA 1990; 87: 4212-4216
67. Tymianski M, Tator CH. Normal and abnormal calcium homeostasis in neurons: A basis for the pathophysiology of traumatic and ischemic central nervous system injury. Neurosurgery 1996; 38: 1176-1195
68. Scatton B. Excitatory amino acid receptor antagonists: A novel treatment for ischemic cerebrovascular diseases. Life Sci 1994; 55: 2115-2124
69. Graham SH, Chen J, Lan JQ, Simon RP. A dose-response study of neuroprotection using the AMPA antagonist NBQX in rat focal cerebral ischemia. J Pharmacol Exp Ther 1996; 276: 1-4
70. Tator CH, Fehlings MG. Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms [see comment]. J Neurosurg 1991; 75: 15-26
71. Holtz A, Gerdin B. MK 801, an OBS N-methyl-D-aspartate channel blocker, does not improve the functional recovery nor spinal cord blood flow after spinal cord compression in rats. Acta Neurol Scand 1991; 84: 334-338